As MMP9 has been shown in the damaged nerves of patients with GBS, and MMP9 expression in leucocytes is correlated to the clinical disability score, the level of peripheral nerve damages can be reflected by the changes in peripheral leukocytes. Here, MMP9 is linked to Guillain-Barre syndrome.